Skip to content

Detection of Clinical-functional Changes Following Exercise Therapy and Neuroscience Education in Institutionalised and Community-dwelling Older Adults Diagnosed With Sarcopenia

Detection of Clinical-functional Changes Following Exercise Therapy and Education in Institutionalised and Community-dwelling Older Adults Diagnosed With Sarcopenia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05875597
Enrollment
50
Registered
2023-05-25
Start date
2023-03-02
Completion date
2023-10-30
Last updated
2023-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aged, Nursing Homes, Resistance Training, Sarcopenia

Brief summary

Nowadays, ageing is an important aspect to consider from a social, healthcare and economic perspective. For this reason, it is necessary to focus on all the elements which can help staying healthy and active in old age. Physical activity and exercise are one of these, and more specifically resistance training.

Detailed description

Recently, it is been evidenced that physical activity and exercise are an important coping strategy to get what is called active ageing. However, it is still under discussion some key aspect, like the training type or the optimal dose, among others. There is a modality of resistance training which it has not been sufficiently studied in old age population: the high intensity interval training. It has been demonstrated in other population (like cardiovascular patients or cancer survivor patients) that this modality of training can improve a lots their physical condition. Furthermore, it produces a higher adhesion to the training program, because it does not require so long time like another type of training. For this reason, the aim of this investigation is to assess how implement this modality of training on elderly people with sarcopenia.

Interventions

OTHERPhysical therapy exercise programme

Carrying out a programme of therapeutic physical exercise for 12 weeks, twice a week for 45 minutes.

Sponsors

University of Extremadura
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Older adults aged 55 years or older. * Living in an institutionalised setting or community-dwelling older adults living in the province of Badajoz or Cáceres. * Voluntarily participating in the study. * Who had a diagnosis of sarcopenia/fragility in the last year. * Submit a prescription from the centre's medical practitioner to participate in the study as physiotherapy intervention would be appropriate and potentially beneficial.

Exclusion criteria

* Patients with cognitive impairment (score ≥24 in the validated Spanish version for general older adults of the Mini-Mental Status Examination). * Unable to tolerate moderate physical activity due to cardiovascular or respiratory disease. * With balance disorders other than those caused by ageing such as dizziness or vestibular disorders requiring the ingestion of medication with a potential effect on balance, as well as balance disorders secondary to the ingestion of any medication or other medical causes. * At high risk of falling (≥ 51 points on the MORSE scale). * At high risk of falling (≥ 51 points on the MORSE scale). * At high risk of falling (≥ 51 points on the MORSE scale).

Design outcomes

Primary

MeasureTime frameDescription
Changes in handgrip strength12 weeksHand-held dynamometer JAMAR
Changes in muscle mass12 weekselectrical bioimpedance
Changes in physical performance12 weeksSPPB test battery
Changes in Funcional Mobility12 weeksMeasured by the Timed Up and Go test (TUG)

Secondary

MeasureTime frameDescription
Changes in Risk of falling12 weeksThe Downton, Tinetti fall risk index was used to assess the risk of falling.
Changes in Health-Related Quality of Life12 weeksWill be measured through the SF-12 health questionnaire.

Countries

Spain

Contacts

Primary ContactLuis Espejo Antunez
luisea@unex.es650057024
Backup ContactLuis Espejo Antúnez
luisea@unex.es650057024

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026